Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023

Author's Avatar
May 11, 2023

BALLI-01 (evaluating UCART22) abstract demonstrates safety and preliminary efficacy of UCART22 in heavily pretreated r/r B-ALL population